URGN - UroGen Pharma Ltd - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

URGN is currently covered by 5 analysts with an average price target of $39.31. This is a potential upside of $10.85 (38.12%) from yesterday's end of day stock price of $28.46.

UroGen Pharma Ltd's activity chart (see below) currently has 103 price targets and 95 ratings on display. The stock rating distribution of URGN is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 49.81% with an average time for these price targets to be met of 241 days.

Highest price target for URGN is $40, Lowest price target is $3, average price target is $27.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 27-Oct-2025. First documented stock forecast 30-May-2017.

Currently out of the existing stock ratings of URGN, 24 are a BUY (88.89%), 3 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$40

$11.19 (38.84%)

$40

1 months 5 days ago
(27-Oct-2025)

6/27 (22.22%)

$19.15 (91.85%)

1019

Buy

$25

$-3.81 (-13.22%)

$25

1 months 5 days ago
(27-Oct-2025)

18/18 (100%)

$4.15 (19.90%)

237

Buy

$31

$2.19 (7.60%)

$10

5 months 19 days ago
(13-Jun-2025)

2/18 (11.11%)

$18.97 (157.69%)

42

Hold

$3

$-25.81 (-89.59%)

$16

6 months 10 days ago
(22-May-2025)

5/10 (50%)

$-1.08 (-26.47%)

454

Buy

$36

$7.19 (24.96%)

8 months 21 days ago
(11-Mar-2025)

1/2 (50%)

$25.18 (232.72%)

94

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is URGN (UroGen Pharma Ltd) average time for price targets to be met?

On average it took 241 days on average for the stock forecasts to be realized with a an average price target met ratio 49.81

Which analyst has the current highest performing score on URGN (UroGen Pharma Ltd) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on URGN (UroGen Pharma Ltd) with a proven track record?

ERIC JOSEPH

Which analyst has the most public recommendations on URGN (UroGen Pharma Ltd)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 3 price targets and 16 ratings on URGN

Which analyst is the currently most bullish on URGN (UroGen Pharma Ltd)?

Matthew Andrews with highest potential upside - $17.19

Which analyst is the currently most reserved on URGN (UroGen Pharma Ltd)?

Paul Choi with lowest potential downside - -$25.81

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?